CK Life unit merges with TransCode as Li Ka-shing firm eyes anticancer drugs pipeline
CK Life Sciences International is set to merge its subsidiary Polynoma with Nasdaq-listed TransCode Therapeutics, in a move expected to boost the pipeline of anticancer drugs, according to the biotech…